From: Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma
 |  | Cases (%) | Controls (%) |
---|---|---|---|
Gender | |||
 | Male | 463 (58%) | 423 (53%) |
 | Female | 334 (42%) | 370 (47%) |
Age group (years) | |||
 | 20-49 | 150 (19%) | 208 (26%) |
 | 50-59 | 194 (24%) | 169 (21%) |
 | 60-69 | 214 (27%) | 206 (26%) |
 | 70+ | 239 (30%) | 210 (26%) |
Ethnicity | |||
 | Caucasian | 625 (78%) | 613 (77%) |
 | Asian | 80 (10%) | 90 (11%) |
 | South Asian | 29 (4%) | 37 (5%) |
 | Mixed/Other | 36 (5%) | 34 (4%) |
 | Unknown/Refused | 27 (3%) | 19 (2%) |
Pathology | |||
   B-cell lymphomas | |||
 | DLBCL | 210 (26%) | - |
 | FL1 | 138 (17%) | - |
 | FL2/FL3 | 78 (10%) | - |
 | MZL/MALT | 92 (12%) | - |
 | MCL | 47 (6%) | - |
 | SLL/CLL | 43 (5%) | - |
 | LPL | 42 (5%) | - |
 | MISC BCL | 71 (9%) | - |
   T-cell lymphomas | |||
 | MF | 40 (5%) | - |
 | PTCL | 29 (4%) | - |
 | MISC TCL | 7 (1%) | - |
Total | Â | 797 (100%) | 793 (100%) |